Latest News

  • AVI BioPharma Announces FDA Clearance of IND Applications for Clinical Trials of RNA Therapeutic Agents for Treatment of Ebola and Marburg Viruses December 23, 2008, PORTLAND, Ore.
  • AVI BioPharma Strengthens its Patent Position in RNA Therapeutics December 23, 2008, PORTLAND, Ore.
  • AVI BioPharma to Present at FDA Public Hearing Regarding Priority Review Vouchers December 11, 2008, PORTLAND, Ore.
  • AVI BioPharma Files IND for Clinical Trial of Marburg Virus Treatment December 3, 2008, PORTLAND, Ore.
  • AVI BioPharma Files IND for Clinical Trial of Ebola Virus Treatment December 3, 2008, PORTLAND, Ore.

News Archives

  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002

Subscribe to the AVI RSS Newsfeed

About AVI BioPharma

  • Home
  • Company Overview
  • Management
  • Annual Report
  • Strategic Alliances
  • Corporate Governance

Technology

  • How RNA Therapeutics Work
  • Chemistry
    (PMO and its new analogs)
  • Applications (TSOs & SSOs)
  • Product Pipeline
  • Publications

Communication

  • News
  • Events
  • Employment
  • Contact Us

©2009 AVI BioPharma | Subscribe to our Feed